These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 1317599)

  • 1. Determinants of virus-related suppression of immune responses as observed during infection with an oncogenic poxvirus.
    Strayer DS
    Prog Med Virol; 1992; 39():228-55. PubMed ID: 1317599
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunohistology of malignant rabbit fibroma virus--a comparative study with rabbit myxoma virus.
    Strayer DS; Sell S
    J Natl Cancer Inst; 1983 Jul; 71(1):105-16. PubMed ID: 6306322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trichinella spiralis as a modulator of Shope fibroma virus.
    Bellelli C; Frosi A; Chiovoloni M; Grelloni V; Baldelli B
    Parassitologia; 1989; 31(2-3):145-52. PubMed ID: 2562107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunologic dysfunction during viral oncogenesis. I. Nonspecific immunosuppression caused by malignant rabbit fibroma virus.
    Strayer DS; Sell S; Skaletsky E; Leibowitz JL
    J Immunol; 1983 Nov; 131(5):2595-600. PubMed ID: 6195270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular analysis of immunosuppression induced by virus replication in lymphocytes.
    Heard HK; O'Connor K; Strayer DS
    J Immunol; 1990 May; 144(10):3992-9. PubMed ID: 2159037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignant rabbit fibroma virus causes secondary immunosuppression in rabbits.
    Strayer DS; Skaletsky E; Cabirac GF; Sharp PA; Corbeil LB; Sell S; Leibowitz JL
    J Immunol; 1983 Jan; 130(1):399-404. PubMed ID: 6292305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant rabbit fibroma virus: observations on the culture and histopathologic characteristics of a new virus-induced rabbit tumor.
    Strayer DS; Cabirac G; Sell S; Leibowitz JL
    J Natl Cancer Inst; 1983 Jul; 71(1):91-104. PubMed ID: 6306326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants of the ability of malignant fibroma virus to induce immune dysfunction and tumor dissemination in vivo.
    Strayer DS; Laybourn KA; Heard HK
    Microb Pathog; 1990 Sep; 9(3):173-89. PubMed ID: 1964998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of virus replication does not alter malignant rabbit fibroma virus-induced immunosuppression.
    Strayer DS; Skaletsky E; Leibowitz JL
    Clin Exp Immunol; 1986 Oct; 66(1):25-36. PubMed ID: 3026700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of virus-induced immune suppression.
    Strayer DS; Leibowitz JL
    J Immunol; 1986 Apr; 136(7):2649-53. PubMed ID: 3005416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunosuppression during viral oncogenesis. IV. Generation of soluble virus-induced immunologic suppressor molecules.
    Strayer DS; Korber K; Dombrowski J
    J Immunol; 1988 Mar; 140(6):2051-9. PubMed ID: 2831278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunosuppression in viral oncogenesis. III. Effects of virus infection on interleukin 1 and interleukin 2 generation and responsiveness.
    Strayer DS; Horowitz M; Leibowitz JL
    J Immunol; 1986 Dec; 137(11):3632-8. PubMed ID: 3023485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming growth factor alpha, Shope fibroma growth factor, and vaccinia growth factor can replace myxoma growth factor in the induction of myxomatosis in rabbits.
    Opgenorth A; Nation N; Graham K; McFadden G
    Virology; 1993 Feb; 192(2):701-9. PubMed ID: 8380671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunosuppression during viral oncogenesis. V. Resistance to virus-induced immunosuppressive factor.
    Strayer DS; Dombrowski J
    J Immunol; 1988 Jul; 141(1):347-51. PubMed ID: 2837511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deletion of the growth factor gene related to EGF and TGF alpha reduces virulence of malignant rabbit fibroma virus.
    Opgenorth A; Strayer D; Upton C; McFadden G
    Virology; 1992 Jan; 186(1):175-91. PubMed ID: 1309274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strain differences in Shope fibroma virus. An immunopathologic study.
    Strayer DS; Skaletsky E; Sell S
    Am J Pathol; 1984 Aug; 116(2):342-58. PubMed ID: 6087669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunologic dysfunction during viral oncogenesis. II. Inhibition of cellular immunity to viral antigens by malignant rabbit fibroma virus.
    Skaletsky E; Sharp PA; Sell S; Strayer DS
    Cell Immunol; 1984 Jun; 86(1):64-74. PubMed ID: 6327086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative effects of virulent and avirulent poxviruses on cell cycle progression.
    Wali A; Strayer DS
    Exp Mol Pathol; 1999 Apr; 66(1):31-8. PubMed ID: 10331962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant rabbit fibroma syndrome. A possible model for acquired immunodeficiency syndrome (AIDS).
    Strayer DS; Sell S; Leibowitz JL
    Am J Pathol; 1985 Jul; 120(1):170-1. PubMed ID: 2990222
    [No Abstract]   [Full Text] [Related]  

  • 20. Virus-lymphocyte interactions during the course of immunosuppressive virus infection.
    Strayer DS; Leibowitz JL
    J Gen Virol; 1987 Feb; 68 ( Pt 2)():463-72. PubMed ID: 3029285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.